SKSerdar Kalemci

Serdar Kalemci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Serdar Kalemci has a total of 90 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Does GATA3 Expression Contribute to the Diagnosis of Renal Tumors With Eosinophilic/Oncocytic Features?

    by Banu Sarsık Kumbaracı, Banu Yaman, Hafize Özdemir, Ceren Utku, Serdar Kalemci, Ali Tekin, Şen Sait

    In recent years, the emergence of newly characterized entities with eosinophilic/oncocytic cytoplasm has posed significant diagnostic challenges, particularly due to the overlapping morphologic features of chromophobe renal cell carcinoma (ChRCC) and renal oncocytoma (RO). In this study, we analyzed the clinicopathological and immunohistochemical (IHC) characteristics of 49 eosinophilic renal tumors to determine whether GATA3 expression could aid in the differential diagnosis of these neoplasms. On the basis of integrated morphologic and IHC evaluation, the tumors were reclassified into the following diagnostic categories: ChRCC (n=15), RO (n=13), unclassified eosinophilic/oncocytic renal cell carcinoma (U-EO-RCC; n=9), low-grade oncocytic tumor (LOT; n=5), and eosinophilic clear cell renal cell carcinoma (E-CCRCC; n=3). In addition, the cohort included single cases of papillary renal neoplasm with reverse polarity (PRNRP), unclassified RCC with MiT family translocation-like features (U-MiTFL-RCC), SDHB-deficient RCC, and FH-deficient RCC. Notably, one of the U-EO-RCC cases was further characterized by the presence of a TSC mutation. All LOT cases, one SDHB-deficient RCC, one FH-deficient RCC, one PRNRP, and one of fifteen chromophobe RCC’s had diffuse/strong staining with GATA3. In contrast, all E-CCRCC (n=3), renal oncocytoma (n=13), and U-MiTFL-RCC (n=1) cases demonstrated complete GATA3 negativity. In conclusion, GATA3 serves as a valuable diagnostic adjunct in the differential diagnosis of emerging eosinophilic renal tumor entities. However, due to its expression across diverse subtypes, GATA3 results must be interpreted within the morphologic context and as part of a comprehensive immunohistochemical panel—including K7, K20, CD117, vimentin, FH, SDHB, and cathepsin K—to avoid potential diagnostic pitfalls and ensure the accurate identification of clinically significant syndromes.

  • Open Access

    Upper Urinary System Changes After Radical Cystectomy and Bricker Urinary Diversion: A Retrospective Evaluation of Functional and Radiological Parameters

    by Alp Akyol, Kasim Emre Ergun, Mustafa Serdar Kalemci, Adnan Simsir, Baris Altay, Mahmut Kusbeci, Fuat Kizilay

    Background/Objectives: Our objective is to evaluate the long-term effects of radical cystectomy and Bricker ileal conduit urinary diversion on upper urinary tract function and structure, with a specific focus on radiological and laboratory changes in renal function. Methods: A retrospective analysis was conducted of 120 patients who underwent radical cystectomy (RC) and Bricker ileal conduit urinary diversion between 2010 and 2024. Clinical, laboratory, and radiological data were assessed over a 24-month follow-up period. Renal parenchymal thickness, kidney volumes, and hydronephrosis grades were analyzed, and the relationship between interventions and renal outcomes was examined. Results: Postoperative follow-up showed a progressive decrease in renal parenchymal thickness and kidney volume, particularly in the left kidney. Hydronephrosis occurred in both renal units, with higher rates on the left side. Despite these changes, only a subset of patients required intervention, typically due to sepsis, acute renal failure, or pain. No significant deterioration in median estimated glomerular filtration rate values was observed; however, patients with interventions showed higher anteroposterior diameter/parenchymal thickness ratios, suggesting increased parenchymal damage. Conclusions: Following radical cystectomy and Bricker ileal conduit diversion, mild to moderate hydronephrosis is not uncommon and does not always necessitate intervention, especially in patients without clinical symptoms. Radiological parameters like renal parenchymal thickness and kidney volume may be valuable for monitoring renal deterioration. Careful follow-up and selective intervention are crucial in preserving renal function in this patient group.

  • Renal cell carcinoma with a novel RAB1A::ALK fusion: expanding the molecular spectrum of ALK-rearranged RCC

    by Claudia Andrea Gómez González, Banu Sarsik Kumbaraci, Fuat Kizilay, Serdar Kalemci, Sercan On, Sait Sen

    Renal cell carcinoma associated with anaplastic lymphoma kinase rearrangement (ALK-RCC) is a rare subtype within the category of molecularly defined renal cell carcinomas. Due to its low incidence and highly heterogeneous clinicopathological features, ALK-RCC poses a significant diagnostic challenge. The implementation of advanced molecular techniques has facilitated the identification of various fusion partners, which may influence clinical behavior and guide targeted therapies. We report a case of ALK-RCC harboring a novel fusion partner, RAB1A::ALK. This report describes the clinicopathological and molecular features of the tumor, with a particular focus on the characterization of the RAB1A gene and its documented impact on carcinogenesis and prognosis across several solid malignancies. Our findings expand the molecular spectrum of ALK-RCC and emphasize the role of comprehensive molecular profiling in uropathology.

  • Open Access

    The Role of Urinary Secretory Immunoglobulin A in the Pathophysiology of Interstitial Cystitis

    by Turan Ozdemir, Bayram Aliyev, Kasim Emre Ergun, Serdar Kalemci, Fuat Kizilay, Elif Azarsiz, Adnan Simsir

    Purpose: This study aimed to determine whether urinary secretory immunoglobulin A (sIgA) levels differ between patients with bladder pain syndrome/interstitial cystitis (BPS/IC) and healthy controls, and to assess whether urinary sIgA is linked to mucosal immune mechanisms that may contribute to BPS/IC pathophysiology.Methods: A single-center, cross-sectional study was conducted between April and June 2020 at the Department of Urology, Ege University Faculty of Medicine. Forty female patients with BPS/IC and 40 healthy controls were enrolled. Symptom severity in the BPS/IC group was evaluated using the O’Leary-Sant Interstitial Cystitis Symptom and Problem Index. Patients with active urogenital infections, a history of bladder cancer, or prior pelvic radiotherapy were excluded. Urine samples were collected in sterile containers, centrifuged, and stored at -80°C before sIgA measurement using a commercial enzyme-linked immunosorbent assay kit. Correlations between continuous variables were examined with Spearman rank correlation coefficients.Results: Urinary sIgA levels were not significantly different between the BPS/IC group (mean±standard deviation: 0.96±1.5 μg/mL) and healthy controls (0.53±0.7 μg/mL) (P=0.173). Subgroup analyses within the BPS/IC cohort showed that smokers had significantly lower urinary sIgA levels (median [range], 0.001 [0.000–0.082] μg/mL) compared with nonsmokers (median [range], 0.720 [0.000–6.850] μg/mL) (P=0.004). Conversely, patients with cardiac comorbidities had significantly higher urinary sIgA levels (median [range], 0.820 [0.100–6.850] μg/mL) than those without cardiac disease (median [range], 0.213 [0.000–2.300] μg/mL) (P=0.015).Conclusions: Although no significant differences in urinary sIgA levels were observed between BPS/IC patients and healthy controls, subgroup analyses identified associations with smoking and cardiac comorbidities. These findings suggest that sIgA may be relevant to BPS/IC pathophysiology and highlight the potential of mucosal immune biomarkers. Larger studies are warranted to further clarify the role of sIgA in BPS/IC.


  • Open Access

    Plasma urotensin-2 levels as a potential biomarker in prostate cancer: Analysis across disease stages

    by Cigdem Dinckal, Zeynep Gulsum Guc, Huriye Erbak Yilmaz, Mustafa Dinckal, Semiha Ozgul, Gamze Ozkan, Kasim Emre Ergun, Mustafa Serdar Kalemci, Sinan Unal, Yasar Yildiz, et al.

    Prostate cancer (PCa) remains a leading cause of cancer-related mortality among men. Although prostate-specific antigen (PSA) is a key biomarker, its diagnostic and prognostic limitations necessitate the identification of novel markers. Urotensin-2 (UT-2), a potent vasoactive peptide, has been implicated in the pathogenesis of several malignancies, but its role in prostate cancer remains underexplored. This study aimed to evaluate plasma UT-2 levels across disease stages in PCa and assess its potential as a biomarker for metastatic disease. This cross-sectional study included 147 male patients: 100 with metastatic PCa and 47 controls (comprising benign prostatic hyperplasia [BPH], localized, and locally advanced PCa). Plasma UT-2 levels were quantified using ELISA. Statistical analyses included analysis of variance, Kruskal–Wallis, and receiver operating characteristic (ROC) curve analysis to assess UT-2’s discriminative ability and its correlation with clinical parameters such as Gleason score, ISUP grade, and PSA. UT-2 levels were significantly elevated in metastatic PCa patients (mean: 2.03 ± 0.91 ng/mL) compared to control groups (BPH: 1.42 ± 0.61 ng/mL; localized: 1.46 ± 0.71 ng/mL; locally advanced: 1.41 ± 0.76 ng/mL; P = .002). ROC analysis demonstrated a moderate discriminatory ability for metastasis (AUC = 0.70, 95% CI: 0.61–0.79), with a cutoff of 1.269 ng/mL yielding 81% sensitivity and 53% specificity. No significant associations were observed between UT-2 levels and Gleason score, ISUP grade, PSA levels, or metastatic site. This is the first clinical study to evaluate plasma UT-2 levels in PCa patients. Elevated UT-2 levels in metastatic cases, independent of traditional prognostic markers, suggest its potential utility in identifying systemic disease burden. While not suitable as a standalone diagnostic tool, UT-2 may serve as a complementary biomarker within a multiparameter panel to improve prognostication and risk stratification in PCa. Further prospective and longitudinal studies are warranted to validate its prognostic significance.


  • Open Access

    PSA dansitesinin robotik radikal prostatektomi sonuçlarına etkisinin incelenmesi

    by Alp Akyol, Kasım Emre Ergün, Serdar Kalemci, Adnan Şimşir, Fuat Kızılay

    Amaç: Prostat spesifik antijen dansitesi (PSAD), prostat kanseri tanısında kullanılan serum prostat spesifik antijen (PSA) düzeyinin prostat volümüne oranlanması ile elde edilen tanısal bir belirteçtir. Prostat büyümesi ile PSA düzeylerindeki artışın korele olması nedeniyle tanısal değerlendirmede bu oran sıklıkla kullanılmaktadır ancak cerrahi sonuçların öngörülmesinde kullanılmamaktadır. Bu çalışmanın amacı, lokalize prostat kanseri için robotik radikal prostatektomi geçiren hastalarda PSA dansitesinin cerrahi sonuçlar ve postoperatif komplikasyonlar üzerindeki etkisini değerlendirmektir. Gereç ve Yöntem: Bu retrospektif kohort çalışması, Temmuz 2020 ile Haziran 2022 arasında robotik RP uygulanan 154 hastanın verilerini analiz etmiştir. PSAD, preoperatif PSA düzeyinin (ng/mL) transrektal ultrason (TRUS) veya multiparametrik MRG ile elde edilen prostat hacmine (mL) oranı olarak hesaplanmıştır. Elektronik dosya arşivi taraması ile toplanan veriler demografik bilgiler, preoperatif PSA düzeyleri, prostat hacmi, cerrahi parametreler ve postoperatif sonuçları içermektedir. Bulgular: Hastaların yaş ortalaması 65 (6,69) olup, yaş aralığı 46 ile 80 arasındadır. Preoperatif PSA düzeyleri 2.19 ile 35.4 ng/mL arasında değişmekte ve ortalama 7,75 (4,73) ng/mL olarak bulunmuştur. Prostat hacmi ortalama 47,73 (16,1) mL'dir. PSAD değerlerinin dağılımında hastaların %18,8'i düşük risk, %34,4'ü orta-düşük risk, %22,1'i orta-yüksek risk ve %24,7'si yüksek risk grubundadır. Daha yüksek PSAD ile pozitif cerrahi sınır oranları %18,75, %31,91, %44,12 ve %51,22 olarak saptanmıştır. PSAD'nin vezikoüretral anastomoz stenozu (VUAS) (p=0.8) veya anastomoz kaçakları (p=0.9) üzerinde anlamlı bir etkisi bulunmamıştır. Lojistik regresyon analizi, PSAD (katsayı 3.02, p=0.051) ve T3a kanserin (katsayı 1.48, p=0.018) pozitif cerrahi sınırların anlamlı prediktörleri olduğunu göstermiştir. ROC eğrisi analizinde, PSAD'nin AUC değerinin (0.65), T3a kanserin AUC değerinden (0.55) daha yüksek olduğu saptanmış olup bu durum PSAD’nin T3a kanserden daha iyi bir pozitif cerrahi sınır belirteci olabileceğini göstermektedir. Sonuç: Bu çalışma, robotik radikal prostatektomi geçiren hastalarda yüksek PSAD'nin pozitif cerrahi sınır riskini artırdığını ve cerrahi sonuçları öngörmede önemli bir biyobelirteç olabileceğini göstermektedir. Ancak, PSAD'nin postoperatif komplikasyonlar üzerinde anlamlı bir etkisi yoktur, bu da daha fazla araştırmaya ihtiyaç olduğunu göstermektedir. PSAD, cerrahi sonuçların iyileştirilmesinde önemli bir rol oynayabilir.

  • Unveiling the bladder’s early response to acute glucosuria: first evidence from an animal study

    by Cemil Emre Yurtseven, Serdar Kalemci, Kasım Emre Ergün, Murat Olukman, Banu Sarsık Kumbaracı, Pınar Toprak, Adnan Şimşir

    Purpose While chronic damage to the lower urinary tract in diabetic patients is well-known, the specific effects of acute glucosuria on the bladder remain unclear. This study, being the first of its kind in the available literature, aims to exclusively investigate the early effects of acute glucosuria on bladder function and morphology, independent of the broader impacts of diabetes. Methods Wistar Albino rats were divided into four groups: CONTROL, Empagliflozin (EMPA), Diabetes Mellitus + Empagliflozin (DM + EMPA), and DM. Acute glucosuria was induced using empagliflozin in the EMPA and DM + EMPA groups. The effects on bladder function were assessed through contraction protocols using potassium chloride (KCl), cumulative acetylcholine (ACh) applications and electrical field stimulation studies (EFS). The bladder tissues were also examined histopathologically to evaluate morphological changes. Results In the organ bath studies, a significant increase in the response to KCl was observed in the diabetic group receiving empagliflozin compared to others (p < 0.001). When examining the contraction responses to ACh, it was found that the diabetic group receiving empagliflozin exhibited significantly higher contraction responses (p < 0.001). In the EFS, no significant difference was found between the groups. The histopathological examinations revealed a significant muscularis propria hypertrophy in the groups receiving empagliflozin compared to the control group (p < 0.001). Conclusions In our study, we found that short-term treatment defined as 15 days with empagliflozin increased the receptor-independent contractile capacity of the bladders in diabetic rats and enhanced their contraction responses to ACh. However, there was no significant difference observed in the EFS studies. Histopathological analysis revealed the development of detrusor hypertrophy in rats receiving empagliflozin treatment.

  • Üst üriner sistem ürotelyal karsinomlarinda tümör boyutu ve yerleşimi sağ kalımı etkiler mi?

    by Serdar Kalemci̇, Kasım Emre ERGÜN, Fuat Kizilay, Adnan Şi̇mşi̇r, Timur Köse

    Aim: This study aimed to evaluate the effect of tumor location based on clinicopathologic features on cancer-specific survival (CSS) of patients who were treated surgically for locally/locally advanced upper tract urothelial carcinoma (UTUC). Materials and Methods: A single-center series of 145 patients with UTUC who underwent radical nephroureterectomy between May 2010 and August 2019 were included in the study. Patients were stratified based on the location of the tumor as renal pelvis and ureter located tumor. Clinicopathologic characteristics and oncological outcomes were compared according to tumor location and CSS rates after surgery were graphically explored using Kaplan–Meier curves. Results: At a mean follow-up time of 41.8 (4-124) months after surgery, 65 patients (44.8%) died from UTUC. Kaplan-Meier curves showed that tumor location was not associated with CSS in the analysis performed according to tumor stage, grade, and size. In the analysis that was conducted without regard to tumor location, worse CSS was found for patients with pT3 disease versus those with ≤pT2 and with high-grade tumors versus those with low-grade (p=0.025 and p=0.011, respectively). Conclusion: Tumor location was not associated with CSS in any of the analyses. Regardless of tumor location, patients with pT3 disease and high-grade tumors, have a worse prognosis. Further studies on prognostic factors are needed to evaluate the advantages of these factors in the management of patients with UTUC.

  • Open Access

    Analysis of risk factors of abdominal wound dehiscence after radical cystectomy

    by Serdar Kalemci, Kasim Emre Ergun, Fuat Kizilay, Bugra Yildiz, Adnan Simsir

    OBJECTIVE: Wound dehiscence is associated with high morbidity and mortality. This study aimed to analyze the risk factors and comorbidities in the patients undergoing radical cystectomy with early postoperative wound dehiscence.METHODS: In all, 539 patients with bladder cancer who underwent radical cystectomy and urinary diversion at a single center between January 2008 and January 2022 were included in the study. The data related to the demographics, medical history, and perioperative clinical features were reviewed. Univariate and multivariate regression analysis was performed to identify risk factors for wound dehiscence.RESULTS: The mean age of the patients was 64.2 years (22-91). The mean body mass index was 26.4 kg/m2 (18.7-35.4). Wound dehiscence was observed in 43 (7.9%) of 539 patients. The patients with wound dehiscence had significantly higher mean BMI (27.8 vs. 26.3, p=0.006), ASA scores (p=0.002), history of chronic obstructive pulmonary disease (30.2 vs. 14.3%, p=0.006), diabetes mellitus (44.2 vs. 17.9%, p=0.003), previous abdominal surgery (18.6 vs. 7.7%, p=0.014), and postoperative ileus (58.1 vs. 16.9%, p=0.006). In the multivariable regression model, diabetes mellitus (odds ratio [OR] 4.9, 95%CI 2.3-10.1; p<0.001), postoperative ileus (OR 8.1, 95%CI 4.1-16.5; p<0.001), and chronic obstructive pulmonary disease (OR 2.6, 95%CI 1.2-5.7; p=0.013) were independent predictors of abdominal wound dehiscence following radical cystectomy. CONCLUSION: Diabetes mellitus, chronic obstructive pulmonary disease, and postoperative ileus were strongly associated with abdominal wound dehiscence following radical cystectomy. Both potential preventive and therapeutic interventions may decrease the risk of wound dehiscence.


  • Comparison of early oncologic and functional results of open and robot-assisted laparoscopic radical prostatectomy

    by Serdar Kalemci̇, Kasım Emre ERGÜN, Tuncer Bahçeci̇, Fuat Kizilay, Burak Turna

    Amaç: Radikal prostatektomi (RP), son yirmi yılda açık cerrahiden minimal invaziv cerrahiye kayda değer bir dönüşüm geçirdi. Çalışmamızda lokalize prostat kanseri nedeniyle açık ve robot yardımlı RP yapılan hastaları erken dönem onkolojik ve fonksiyonel sonuçları açısından karşılaştırılmayı amaçladık. Gereç ve Yöntem: Çalışmamıza Ocak 2009 ile Ocak 2014 tarihleri arasında prostat kanseri tanısı alıp RP yapılan 537 hasta dâhil edildi. (Açık retropubik radikal prostatektomi (ARRP)=387, robot yardımlı laparoskopik radikal prostatektomi (RYRP)=150). Hastaların demografik verileri, perioperatif ve postoperatif sonuçları iki grup arasında karşılaştırıldı. Bulgular: Hastaların ortalama yaşı ARRP grubunda 62,9 (46-76), RYRP grubunda ise 61,1 (42-76) yıl idi. Ortalama hastanede kalış süresi, üretral kateterizasyon süresi ve kan transfüzyonu ihtiyacının RYRP grubunda anlamlı olarak daha kısa olduğu görüldü. Cerrahi sınır pozitifliği oranlarının pT2 evreye sahip olanlarda ARRP ve RYRP grubu için sırasıyla %16,3 ve %20 (p=0,412), pT3 evreye sahip olanlarda ise ARRP ve RYRP grubunda sırasıyla %40,9 ve %68,8 (p=0,05) olduğu görüldü. Ortalama takip süresi, ARRP grubunda 30,6 (3-64) ay, RYRP grubunda ise 11,3 (1-24) ay olarak hesaplandı. Takipte RYRP grubunda anastomoz darlığı ve biyokimyasal rekürrens gelişiminin daha az olduğu görüldü (%3,9 vs %29,9 p